UniProtKB/Swiss-Prot P01579: Variant p.Lys29Gln

Interferon gamma
Gene: IFNG
Feedback?

Variant information Variant position:

29 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Lysine (K) to Glutamine (Q) at position 29 (K29Q, p.Lys29Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (K) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Sequence information Variant position:

29 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

166 The length of the canonical sequence.
Location on the sequence:

AFQLCIVLGSLGCYCQDPYV K EAENLKKYFNAGHSDVADNG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         AFQLCIVLGSLGCYCQD----PYVKEAENLKKYFNAGHSDVADNG

                              AFQLCVILCSSGCNCQA----MFFKEIENLKEYFNASNPDV

Rhesus macaque                AFQLCIVLGSLGCYCQD----PYVKEAENLKKYFNAGDPDV

Mouse                         ALQLFLMAVS-GCYCHG----TVIESLESLNNYFNSSGIDV

Rat                           VLQLCLMALS-GCYCQG----TLIESLESLKNYFNSSSMDA

Pig                           AFQLCVTLCFSGSYCQA----PFFKEITILKDYFNASTSDV

Bovine                        ALLLCGLLGFSGSYGQG----QFFREIENLKEYFNASSPDV

Rabbit                        AFQLCLILGSYGCYCQD----TLTRETEHLKAYLKANTSDV

Goat                          ALLLSVLLGFSGSYGQG----PFFKEIENLKEYFNASNPDV

Sheep                         ALLLCVLLGFSGSYGQG----PFFKEIENLKEYFNASNPDV

Cat                           AFQLCIILCSSGYYCQA----MFFKEIEELKGYFNASNPDV

Horse                         AFQLCAILGSSTYYCQA----AFFKEIENLKEYFNASNPDV

Chicken                       -FVLSVIMIYYGHTASSLNLVQLQDDIDKLKADFNSSHSDV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	24 – 161	Interferon gamma
Modified residue	24 – 24	Pyrrolidone carboxylic acid
Glycosylation	48 – 48	N-linked (GlcNAc...) asparagine
Helix	27 – 38

Literature citations
No reference for the current variant in UniProtKB/Swiss-Prot.

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.